ESC Premium Access

Duration of dual antiplatelet therapy in patients treated with second generation drug-eluting stents: a systematic review and meta-analysis

Congress Presentation

About the speaker

Doctor Matteo Bianco

San Luigi Gonzaga University Hospital, Orbassano (Italy)
1 presentation
0 follower

5 more presentations in this session

Clinical outcomes in patients with diabetes mellitus receiving dual antiplatelet therapy more than 12 months after second-generation drug eluting stent implantation

Speaker: Doctor S. Cho (Goyang, KR)

Thumbnail

longer dual antiplatelet therapy beyond 9 months does not influence neointimal condition after second generation drug eluting stent implantation

Speaker: Doctor Y. Goryo (Kurashiki, JP)

Thumbnail

Longer-term oral antiplatelet use in stable post-MI patients: Insights from the TIGRIS study

Speaker: Doctor S. Goodman (Toronto, CA)

Thumbnail

Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation in patients with or without diabetes: a patient-level meta-analysis of randomised trials

Speaker: Doctor G. Gargiulo (Naples, IT)

Thumbnail

Long term dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised studies

Speaker: Doctor G. Ferrante (Rozzano, IT)

Thumbnail

Access the full session

Dual antiplatelet therapy: the long and the short of it!

Speakers: Doctor M. Bianco, Doctor S. Cho, Doctor Y. Goryo, Doctor S. Goodman, Doctor G. Gargiulo...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk